Company intelligence / Profile preview
Tianjin Angsai Cell Gene Engineering Co., Ltd.
Tianjin, Chinadnb.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Tianjin Angsai Cell Gene Engineering Co., Ltd. is a biotech and pharma company specializing in cell and gene therapy. It develops stem cell, gene editing, and tissue engineering products, focusing on treating refractory diseases across multiple systems, with several indications currently under clinical development or pending approval.
- Therapeutic areas
- GastroenterologyPulmonologyImmunologyNeurology
- Modalities
- Stem cell therapiesIn vivo gene editing therapiesTissue engineering products
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Tianjin Angsai Cell Gene Engineering Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tianjin Angsai Cell Gene Engineering Co., Ltd..